Accelmed Partners II Acquires TearLab Corporation
July 9, 2020
Accelmed Partners II (AP-II) has completed a buyout of TearLab Corporation, a developer of point-of-care tear diagnostic devices, positioning the company as a private entity to pursue development of its next-generation Discovery platform and targeted acquisitions. The transaction includes a planned investment to support growth, pay down debt, and build a comprehensive dry eye care platform for eyecare professionals and patients.
- Buyers
- Accelmed Partners II (AP-II)
- Targets
- TearLab Corporation
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.